Business Combinations - Purchase Allocation (Details) $ in Thousands, $ in Millions				1 Months Ended		6 Months Ended		9 Months Ended
	Jan. 04, 2022 USD ($)	Oct. 01, 2021 USD ($)	Aug. 27, 2021 CAD ($)	Jan. 31, 2022 USD ($)	Oct. 31, 2021 USD ($)	Jun. 30, 2022 USD ($)	Jun. 30, 2021 USD ($)	Jun. 30, 2022 USD ($)	Dec. 31, 2021 USD ($)
Purchase price - cash consideration
Net cash paid						$ 8,705	$ 0
Fair value of net assets and liabilities assumed:
Goodwill						125,738		$ 125,738	$ 115,206
Symeo GmbH
Purchase price - cash consideration
Less: cash acquired				$ (1,295)
Net cash paid	$ 8,705			18,379
Purchase price - equity consideration
Purchase price - equity consideration				0
Earn out shares				8,204
Contingent consideration				0
Net consideration				26,583
Fair value of net assets and liabilities assumed:
Current assets other than cash						2,857		2,857
Property and equipment						1,039		1,039
Other non-current assets						36		36
Current liabilities						(1,461)		(1,461)
Deferred revenue						0		0
Deferred tax liabilities, non-current						(2,935)		(2,935)
Long-term debt						0		0
Total fair value of net assets acquired						12,316		12,316
Goodwill						14,267		14,267
Symeo GmbH | Initial Cash Considation
Purchase price - cash consideration
Purchase price - cash consideration				10,000
Symeo GmbH | Cash Consideration Accural
Purchase price - cash consideration
Purchase price - cash consideration				9,674
Symeo GmbH | Cash Consideration, Debt Repaid
Purchase price - cash consideration
Purchase price - cash consideration				0
Symeo GmbH | Purchase price - equity consideration
Purchase price - equity consideration
Purchase price - equity consideration
Symeo GmbH | Common stock
Purchase price - equity consideration
Purchase price - equity consideration				0
Symeo GmbH | Option
Purchase price - equity consideration
Purchase price - equity consideration				$ 0
Symeo GmbH | IPR&D
Fair value of net assets and liabilities assumed:
In-progress research & development						2,170		2,170
Symeo GmbH | Developed technology
Fair value of net assets and liabilities assumed:
Intangible asset, finite lived						6,631		6,631
Symeo GmbH | Customer relationships
Fair value of net assets and liabilities assumed:
Intangible asset, finite lived						2,411		2,411
Symeo GmbH | Backlog
Fair value of net assets and liabilities assumed:
Intangible asset, finite lived						603		603
Symeo GmbH | Trade names
Fair value of net assets and liabilities assumed:
Intangible asset, finite lived						965		965
TeraXion
Purchase price - cash consideration
Less: cash acquired					$ (5,625)
Net cash paid					75,282
Purchase price - equity consideration
Purchase price - equity consideration					82,441
Earn out shares					0
Contingent consideration					0
Net consideration			$ 200		157,723
Fair value of net assets and liabilities assumed:
Current assets other than cash						7,627		7,627
Property and equipment						6,009		6,009
Other non-current assets						0		0
Current liabilities						(5,840)		(5,840)
Deferred revenue						(1,025)		(1,025)
Deferred tax liabilities, non-current						(20,272)		(20,272)
Long-term debt						(7,580)		(7,580)
Total fair value of net assets acquired						54,002		54,002
Goodwill						103,721		103,721
TeraXion | Initial Cash Considation
Purchase price - cash consideration
Purchase price - cash consideration					74,050
TeraXion | Cash Consideration Accural
Purchase price - cash consideration
Purchase price - cash consideration					0
TeraXion | Cash Consideration, Debt Repaid
Purchase price - cash consideration
Purchase price - cash consideration					6,857
TeraXion | Purchase price - equity consideration
Purchase price - equity consideration
Purchase price - equity consideration
TeraXion | Common stock
Purchase price - equity consideration
Purchase price - equity consideration					65,192
TeraXion | Option
Purchase price - equity consideration
Purchase price - equity consideration					17,249
TeraXion | IPR&D
Fair value of net assets and liabilities assumed:
In-progress research & development						10,304		10,304
TeraXion | Developed technology
Fair value of net assets and liabilities assumed:
Intangible asset, finite lived						43,594		43,594
TeraXion | Customer relationships
Fair value of net assets and liabilities assumed:
Intangible asset, finite lived						12,682		12,682
TeraXion | Backlog
Fair value of net assets and liabilities assumed:
Intangible asset, finite lived						2,378		2,378
TeraXion | Trade names
Fair value of net assets and liabilities assumed:
Intangible asset, finite lived						6,125		6,125
ON Design Israel
Purchase price - cash consideration
Purchase price - cash consideration								5,000
Less: cash acquired					(1,133)
Net cash paid		$ 4,974			12,474
Purchase price - equity consideration
Purchase price - equity consideration					0
Earn out shares					0
Contingent consideration		$ 4,000			4,000
Net consideration					16,474
Fair value of net assets and liabilities assumed:
Current assets other than cash						119		119
Property and equipment						1,315		1,315
Other non-current assets						66		66
Current liabilities						(859)		(859)
Deferred revenue						0		0
Deferred tax liabilities, non-current						(1,578)		(1,578)
Long-term debt						0		0
Total fair value of net assets acquired						5,702		5,702
Goodwill						10,772		10,772
ON Design Israel | Initial Cash Considation
Purchase price - cash consideration
Purchase price - cash consideration					6,107
ON Design Israel | Cash Consideration Accural
Purchase price - cash consideration
Purchase price - cash consideration					7,500
ON Design Israel | Cash Consideration, Debt Repaid
Purchase price - cash consideration
Purchase price - cash consideration					0
ON Design Israel | Purchase price - equity consideration
Purchase price - equity consideration
Purchase price - equity consideration
ON Design Israel | Common stock
Purchase price - equity consideration
Purchase price - equity consideration					0
ON Design Israel | Option
Purchase price - equity consideration
Purchase price - equity consideration					$ 0
ON Design Israel | IPR&D
Fair value of net assets and liabilities assumed:
In-progress research & development						1,562		1,562
ON Design Israel | Developed technology
Fair value of net assets and liabilities assumed:
Intangible asset, finite lived						5,077		5,077
ON Design Israel | Customer relationships
Fair value of net assets and liabilities assumed:
Intangible asset, finite lived						0		0
ON Design Israel | Backlog
Fair value of net assets and liabilities assumed:
Intangible asset, finite lived						0		0
ON Design Israel | Trade names
Fair value of net assets and liabilities assumed:
Intangible asset, finite lived						$ 0		$ 0